Go to the content. | Move to the navigation | Go to the site search | Go to the menu | Contacts | Accessibility

| Create Account

Facchin, Michela (2018) Clinical and Hemodynamic Results after Transcatheter Aortic Valve implantation (TAVI): Early and Late (10-year) follow-up. [Ph.D. thesis]

Full text disponibile come:

[img]
Preview
PDF Document
2210Kb

Abstract (english)

Transcatheter aortic valve implantation (TAVI) has become the treatment of choice in patients with severe symptomatic aortic stenosis (AS) considered inoperable or at high surgical risk. More recently, TAVI has been performed also to lower risk patients based on the Heart Team decision. Few studies have studied interaction between surgical risk categories and outcomes.
Aim of the study
To analyze safety and efficacy (VARC-2 defined) TAVI treated patients as function of different preoperative risk. To assess independent predictors of death.
Methods
Four-hundred-eighty-two patients who underwent TAVI in our center between 2007 and 2017 were included in the study. According to Society of Thoracic Surgeons (STS) score and to other parameters, all the patients were retrospectively stratified into 4 groups: prohibitive (contraindications to aortic valve replacement, n = 124), high (STS > 8, n = 131), intermediate (4 ≤ STS ≤ 8, n = 112) and low (STS < 4, n = 115) risk. Early, 1-year and long-term outcomes have been evaluated in those 4 groups according the VARC 2 criteria.
Results
The TAVI procedure resulted to be safe because of low mortality rate throughout all risk groups. The lowest 30-days mortality rate was observed in low and prohibitive-risk patients (p=0.048). In the low risk group, in-hospital mortality was 0%. The results were similar at 1-year of follow-up, with a mortality rate of 6% and 7% in low- and prohibitive-risk patients vs 21% and 19% in intermediate- and high-risk groups, (p<0.008). At 5-year of follow-up the mortality rate was 52% and it appeared to be lower only in low-risk patients at long-term follow-up. Independent predictors of mortality were pre-procedural congestive heart failure (CHF), neoplastic disease, pre-procedural-creatinine, post-procedural major or life threatening bleeding and post-procedural acute kidney injury (AKI). Implanted prosthesis performed well with stable hemodynamic results over time and rare dysfunction (2.1%).
Conclusions
In our study population, TAVI was safe and effective, with low rates of mortality and adverse events regardless of the surgical risk. At longer follow-up mortality rate was significantly lower in low-risk patients. Pre-procedural CHF, neoplastic diseases, pre-procedural creatinine, post-procedural severe bleedings and post-procedural AKI were independent predictors of mortality. Transcatheter heart valves (THV) performance after the procedure was excellent and stable over time with low rate of late prosthesis dysfunction. Further studies should be addressed to confirm the promising long-term results among low-risk patients and the long-term durability of THV.


Statistiche Download
EPrint type:Ph.D. thesis
Tutor:Tarantini, Giuseppe
Ph.D. course:Ciclo 29 > Corsi 29 > SCIENZE MEDICHE, CLINICHE E SPERIMENTALI
Data di deposito della tesi:30 January 2018
Anno di Pubblicazione:30 January 2018
Key Words:Aortic stenosis, TAVI, Prosthesis dysfunction
Settori scientifico-disciplinari MIUR:Area 06 - Scienze mediche > MED/11 Malattie dell'apparato cardiovascolare
Struttura di riferimento:Dipartimenti > Dipartimento di Scienze Cardiologiche, Toraciche e Vascolari
Codice ID:11098
Depositato il:25 Oct 2018 16:17
Simple Metadata
Full Metadata
EndNote Format

Bibliografia

I riferimenti della bibliografia possono essere cercati con Cerca la citazione di AIRE, copiando il titolo dell'articolo (o del libro) e la rivista (se presente) nei campi appositi di "Cerca la Citazione di AIRE".
Le url contenute in alcuni riferimenti sono raggiungibili cliccando sul link alla fine della citazione (Vai!) e tramite Google (Ricerca con Google). Il risultato dipende dalla formattazione della citazione.

1. Ross J, Braunwald E. Aortic stenosis. Circulation. 1968;38:61-67 Cerca con Google

2. Kelly TA, Rothbart RM, Cooper CM, Kaiser DL, Smucker ML, Gibson RS. Comparison of outcome of asymptomatic to symptomatic patients older that 20 years of age with valvular aortic stenosis. Am J Cardiol. 1988;61:123-130 Cerca con Google

3. Lindroos M, Kupari M, Heikkila J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol. 1993;21:1220-1225. Cerca con Google

4. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med. 1999; 341:142-147 Cerca con Google

5. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. The Lancet 2006 September 16,;368(9540):1005-1011. Cerca con Google

6. Osnabrugge RLJ, Mylotte D, Head SJ, Van Mieghem NM, Nkomo VT, LeReun CM, et al. Aortic Stenosis in the Elderly. Journal of the American College of Cardiology 2013 September 10,;62(11):1002-1012. Cerca con Google

7. Thaden JJ, Nkomo VT, Enriquez-Sarano M. The Global Burden of Aortic Stenosis. Progress in Cardiovascular Diseases 2014 May 1,;56(6):565-571. Cerca con Google

8. Mann DL, Zipes DP, Libby P, Bonow RO. Malattie del cuore di Braunwald . 10th ed.; 2016. Cerca con Google

9. Rosenhek R, Zilberszac R, Schemper M, Czerny M, Mundigler G, Graf S, et al. Natural history of very severe aortic stenosis. Circulation 2010 Jan 5;121(1):151-156. Cerca con Google

10. Turina J, Hess O, Sepulcri F, Krayenbuehl HP. Spontaneous course of aortic valve disease. Eur Heart J 1987 May;8(5):471-483. Cerca con Google

11. Horstkotte D, Loogen F. The natural history of aortic valve stenosis. Eur Heart J 1988 Apr;9 Suppl E:57-64. Cerca con Google

12. Dahl JS, Christensen NL, Videbæk L, Poulsen MK, Carter-Storch R, Hey TM, Pellikka PA, Steffensen FH, Møller JE. Left Ventricular Diastolic Function Is Associated with Symptom Status in Severe Aortic Valve Stenosis. Circ Imaging. 2013;10:1161 Cerca con Google

13. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O'Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM 3rd, Thomas JD; ACC/AHA Task Force Members. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Jun 10;129(23):e521-643 Cerca con Google

14. Di Pasquale G, Coutsoumbas GV, Zagnoni S. Severe low-gradient aortic stenosis, with preserved ventricular function: should it be treated? J Cardiovasc Med (Hagerstown). 2017 Jan;18 Suppl 1 Cerca con Google

15. Rosenhek R, Maurer G, Baumgartner H. Should early elective surgery be performed in patients with severe but asymptomatic aortic stenosis? Eur Heart J 2002;23:1417–1421. Cerca con Google

16. Pendyala LK, Ben-Dor I, Waksman R. Evolution of percutaneous balloon aortic valvuloplasty in the treatment of patients with aortic stenosis. Minerva Med 2012;103:415–429 Cerca con Google

17. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, Derumeaux G, Anselme F, Laborde F, Leon MB. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002;106:3006–3008. Cerca con Google

18. Harken DE, Soroff HS, Taylor WJ, Lefemine AA, Gupta SK, Lunzer S. Partial and complete prostheses in aortic insufficiency. J Thorac Cardiovasc Surg 1960;40: 744–762. Cerca con Google

19. Helmut Baumgartner Volkmar Falk Jeroen J. Bax Michele De Bonis Christian Hamm Per Johan Holm Bernard Iung Patrizio Lancellotti Emmanuel Lansac Daniel Rodriguez Muñoz Raphael Rosenhek Johan Sjögren Pilar Tornos Mas Alec Vahanian Thomas Walther Olaf Wendler Stephan Windecker Jose Luis Zamorano ESC Scientific Document Group. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. European Heart Journal, Volume 38, Issue 36, 21 September 2017, Pages 2739–2791. Cerca con Google

20. O'Brien SM, Shahian DM, Filardo G, Ferraris VA, Haan CK, Rich JB, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery. Ann Thorac Surg 2009 Jul;88(1 Suppl):23. Cerca con Google

21. Schymik G, Heimeshoff M, Bramlage P, Herbinger T, Wu¨rth A, Pilz L, Schymik JS, Wondraschek R, Su¨selbeck T, Gerhardus J, Luik A, Gonska BD, Tzamalis P, Posival H, Schmitt C, Schro¨ fel H. A comparison of transcatheter aortic valve implantation and surgical aortic valve replacement in 1, 141 patients with severe symptomatic aortic stenosis and less than high risk. Cathet Cardiovasc Interv 2015; 86:738–744. Cerca con Google

22. Tokarek T, Sobczynski R, Dziewierz A, Siudak Z, Zasada W, Sorysz D, Pfitzner R, Sadowski J, De˛bski G, Dziewie˛cka E, Gruszka K, Dudek D. Clinical outcomes in patients after surgical and transcatheter aortic valve replacement. Pol Arch Med Wewn 2015;125:755–764. Cerca con Google

23. Tamburino C, Barbanti M, D’Errigo P, Ranucci M, Onorati F, Covello RD, SantiniF, Rosato S, Santoro G, Fusco D, Grossi C, Seccareccia F; OBSERVANT Research Group. 1-year outcomes after transfemoral transcatheter or surgical aortic valve replacement: results from the Italian OBSERVANT Study. J Am CollCardiol 2015;66:804–812. Cerca con Google

24. Fraccaro C, Tarantini G, Rosato S, Tellaroli P, D’Errigo P, Tamburino C, OnoratiF, Ranucci M, Barbanti M, Grossi C, Santoro G, Santini F, Covello RD, Fusco D, Seccareccia F; OBSERVANT Research Group. Early and midterm outcome of propensity-matched intermediate-risk patients aged >_80 years with aortic stenosis undergoing surgical or transcatheter aortic valve replacement (from the Italian Multicenter OBSERVANT Study). Am J Cardiol 2016;117:1494–1501. Cerca con Google

25. Thourani VH, Kodali S, Makkar RR, Herrmann HC, Williams M, Babaliaros V, Smalling R, Lim S, Malaisrie SC, Kapadia S, Szeto WY, Greason KL, Kereiakes D, Ailawadi G, Whisenant BK, Devireddy C, Leipsic J, Hahn RT, Pibarot P,Weissman NJ, Jaber WA, Cohen DJ, Suri R, Tuzcu EM, Svensson LG, Webb JG, Moses JW, Mack MJ, Miller DC, Smith CR, Alu MC, Parvataneni R, D’Agostino RB, Leon MB. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet 2016; 387:2218–2225. Cerca con Google

26. Ferguson TB Jr, Dziuban SW Jr, Edwards FH, Eiken MC, Shroyer AL, Pairolero PC, Anderson RP, Grover FL. The STS National Database: current changes and challenges for the new millennium. Committee to Establish a National Database in Cardiothoracic Surgery, the Society of Thoracic Surgeons. Ann Thorac Surg 2000;69:680–691. Cerca con Google

27. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999;16:9–13. Cerca con Google

28. Nashef SA, Roques F, Sharples LD, Nilsson J, Smith C, Goldstone AR, Lockowandt U. EuroSCORE II. Eur J Cardiothorac Surg 2012;41:734–744; discussion 744–5. Cerca con Google

29. Thourani VH, Suri RM, Gunter RL, Sheng S, O’Brien SM, Ailawadi G, Szeto WY, Dewey TM, Guyton RA, Bavaria JE, Babaliaros V, Gammie JS, Svensson L, Williams M, Badhwar V, Mack MJ. Contemporary real-world outcomes of surgical aortic valve replacement in 141, 905 low-risk, intermediate-risk, and high-risk patients. Ann Thorac Surg 2015;99:55–61. Cerca con Google

30. Tran HA, Roy SK, Hebsur S, Barnett SD, Schlauch KA, Hunt SL, Holmes SD, Ad N. Performance of four risk algorithms in predicting intermediate survival in patients undergoing aortic valve replacement. Innovations (Phila) 2010;5:407–412. Cerca con Google

31. Seiffert M, Sinning JM, Meyer A, Wilde S, Conradi L, Vasa-Nicotera M, Ghanem A, Kempfert J, Hammerstingl C, Ojeda FM, Kim WK, Koschyk DH, Schirmer J, Baldus S, Grube E, Mo¨llmann H, Reichenspurner H, Nickenig G, Blankenberg S, Diemert P, Treede H, Walther T, Werner N, Schnabel RB. Development of a risk score for outcome after transcatheter aortic valve implantation. Clin Res Cardiol 2014;103:631–640. Cerca con Google

32. Edwards FH, Cohen DJ, O’Brien SM, Peterson ED, Mack MJ, Shahian DM, Grover FL, Tuzcu EM, Thourani VH, Carroll J, Brennan JM, Brindis RG, Rumsfeld J, Holmes DR, Steering Committee of the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. Development and validation of a risk prediction model for in-hospital mortality after transcatheter aortic valve replacement. JAMA Cardiol 2016;1:46–52. Cerca con Google

33. D’Ascenzo F, Capodanno D, Tarantini G, Nijhoff F, Ciuca C, Rossi ML, Brambilla N, Barbanti M, Napodano M, Stella P, Saia F, Ferrante G, Tamburino C, Gasparetto V, Agostoni P, Marzocchi A, Presbitero P, Bedogni F, Cerrato E, Omede` P, Conrotto F, Salizzoni S, Biondi Zoccai G, Marra S, Rinaldi M, Gaita F, D’Amico M, Moretti C. Usefulness and validation of the survival posT TAVI score for survival after transcatheter aortic valve implantation for aortic stenosis. Am J Cardiol 2014;114:1867–1874. Cerca con Google

34. Debonnaire P, Fusini L, Wolterbeek R, Kamperidis V, van Rosendael P, van der Kley F, Katsanos S, Joyce E, Tamborini G, Muratori M, Gripari P, Bax JJ, Marsan NA, Pepi M, Delgado V. Value of the " TAVI2-SCORe" versus surgical risk scores for prediction of one year mortality in 511 patients who underwent transcatheter aortic valve implantation. Am J Cardiol 2015;115:234–242. Cerca con Google

35. Hermiller JB, Yakubov SJ, Reardon MJ, Deeb GM, Adams DH, Afilalo J, Huang J, Popma JJ; CoreValve United States Clinical Investigators. Predicting early and late mortality after transcatheter aortic valve replacement. J Am Coll Cardiol 2016;68: 343–352. Cerca con Google

36. Kotting J, Schiller W, Beckmann A, Schafer E, Dobler K, Hamm C, Veit C, Welz A. German Aortic Valve Score: a new scoring system for prediction of mortality related to aortic valve procedures in adults. Eur J Cardiothorac Sur 2013;43: 971–977. Cerca con Google

37. Agarwal S, Garg A, Parashar A, Svensson LG, Tuzcu EM, Navia JL, Mick S, Kapadia SR. In-hospital mortality and stroke after surgical aortic valve replacement: a nationwide perspective. J Thorac Cardiovasc Surg 2015;150:571–578.e8. Cerca con Google

38. Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, Fontana GP, Dewey TM, Thourani VH, Pichard AD, Fischbein M, Szeto WY, Lim S,Greason KL, Teirstein PS, Malaisrie SC, Douglas PS, Hahn RT, Whisenant B, Zajarias A, Wang D, Akin JJ, Anderson WN, Leon MB; PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012;366:1686–1695. Cerca con Google

39. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, Isasi CR, Jime´nez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Mackey RH, Matsushita K, Mozaffarian D, Mussolino ME, Nasir K, Neumar RW, Palaniappan L, Pandey DK, Thiagarajan RR, Reeves MJ, Ritchey M, Rodriguez CJ, Roth GA, Rosamond WD, Sasson C, Towfighi A, Tsao CW, Turner MB, Virani SS, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation 2017;135:e146–e603. Cerca con Google

40. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S, PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597–1607. Cerca con Google

41. Deeb GM, Reardon MJ, Chetcuti S, Patel HJ, Grossman PM, Yakubov SJ, Kleiman NS, Coselli JS, Gleason TG, Lee JS, Hermiller JB Jr, Heiser J, Merhi W, Zorn GL 3rd, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Maini B, Mumtaz M, Conte J, Resar J, Aharonian V, Pfeffer T, Oh JK, Qiao H, c DH, Popma JJ, CoreValve US Clinical Investigators. 3-year outcomes in high-risk patients who underwent surgical or transcatheter aortic valve replacement. J Am Coll Cardiol 2016;67:2565–2574. Cerca con Google

42. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ, PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011;364:2187–2198. Cerca con Google

43. Mack MJ, Leon MB, Smith CR, Miller DC, Moses JW, Tuzcu EM, Webb JG, Douglas PS, Anderson WN, Blackstone EH, Kodali SK, Makkar RR, Fontana GP, Kapadia S, Bavaria J, Hahn RT, Thourani VH, Babaliaros V, Pichard A, Herrmann HC, Brown DL, Williams M, Akin J, Davidson MJ, Svensson LG, PARTNER 1 Trial Investigators. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 2015;385:2477–2484. Cerca con Google

44. Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, Gleason TG, Buchbinder M, Hermiller J Jr, Kleiman NS, Chetcuti S, Heiser J, Merhi W, Zorn G, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Conte J, Maini B, Mumtaz M, Chenoweth S, Oh JK, U.S. CoreValve Clinical Investigators. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 2014;370:1790–1798. Cerca con Google

45. Thyregod HG, Steinbruchel DA, Ihlemann N, Nissen H, Kjeldsen BJ, Petursson P, Chang Y, Franzen OW, Engstrom T, Clemmensen P, Hansen PB, Andersen LW, Olsen PS, Sondergaard L. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical trial. J Am Coll Cardiol 2015;65:2184–2194. Cerca con Google

46. Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, Thourani VH, Tuzcu EM, Miller DC, Herrmann HC, Doshi D, Cohen DJ, Pichard AD, Kapadia S, Dewey T, Babaliaros V, Szeto WY, Williams MR, Kereiakes D, Zajarias A, Greason KL, Whisenant BK, Hodson RW, Moses JW, Trento A, Brown DL, Fearon WF, Pibarot P, Hahn RT, Jaber WA, Anderson WN, Alu MC, Webb JG, PARTNER 2 Investigators. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 2016;374:1609–1620. Cerca con Google

47. Siontis GC, Praz F, Pilgrim T, Mavridis D, Verma S, Salanti G, Sondergaard L, Juni P, Windecker S. Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of severe aortic stenosis: a meta-analysis of randomized trials. Eur Heart J 2016;37:3503–3512. Cerca con Google

48. Reardon MJ, Van Mieghem NM, Popma JJ, Kleiman NS, Sondergaard L, Mumtaz M, Adams DH, Deeb GM, Maini B, Gada H, Chetcuti S, Gleason T, Heiser J, Lange R, Merhi W, Oh JK, Olsen PS, Piazza N, Williams M, Windecker S, Yakubov SJ, Grube E, Makkar R, Lee JS, Conte J, Vang E, Nguyen H, Chang Y, Mugglin AS, Serruys PW, Kappetein AP, SURTAVI Investigators. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med 2017;376:1321–1331. Cerca con Google

49. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Fleisher LA, Jneid H, Mack MJ, McLeod CJ, O'Gara PT, Rigolin VH, Sundt TM 3rd, Thompson A. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017 Jun 20;135(25):e1159-e1195 Cerca con Google

50. Walther T,DeweyT,Borger MA, Kempfert J, Linke A, becht R, FalkV, Schuler G, Mohr FW, Mack M,. Transapical aortic valve implantation: step by ptep. Ann Thorac Surg. 2009;87:276-283. Cerca con Google

51. Grube E, Buellesfeld L, Mueller R, Sauren B, Zickmann B, Nair D, Beucher H, Felderhoff T, Iversen S, Gerckens U. Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve Revalving system. Circ Cardiovasc Interv. 2008;1:167-175. Cerca con Google

52. Willson AB, Webb JG, Labounty TM, Achenbach S, Moss R, Wheeler M et al. 3-dimensional aortic annular assessment by multidetector computed tomography predicts moderate or severe paravalvular regurgitation after transcatheter aortic valve replacement: a multicenter retrospective analysis. J Am Coll Cardiol 2012;59:1287-94. Cerca con Google

53. Binder RK, Rodés-Cabau J, Wood RA, Mok M, Leipsic J, De Larochellière R et al. Transcatheter aortic valve replacement with the SAPIEN 3. A new balloon-expandable transcatheter heart valve. JACC Cardiovascular Intervention 2013;6:293-300. Cerca con Google

54. Tarantini G, Gasparetto V, Napodano M, Fraccaro C, Gerosa G, Isabella G. Valvular leak after transcatheter aortic valve implantation: a clinician update on epidemiology, pathophysiology and clinical implications. Am J Cardiovasc Dis 2011;1:312-20. Cerca con Google

55. Fraccaro C, Napodano M, Tarantini G. Conduction disorders in the setting of transcatheter aortic valve implantation: a clinical perspective. Catheter Cardiovasc Interv 2013;81:1217-23. Cerca con Google

56. Fraccaro C, Buja G, Tarantini G, Gasparetto V, Leoni L, Razzolini R et al. Incidence, predictors, and outcome of conduction disorders after transcatheter self-expandable aortic valve implantation. Am J Cardiol 2011;107:747-54. Cerca con Google

57. Facchin M, Mojoli M, Covolo E, Tarantini G. The SAPIEN 3 valve: lights and shadows. Minerva Med. 2014 Dec;105(6):497-500. Cerca con Google

58. Tarantini G, Mojoli M, Purita P, Napodano M, D'Onofrio A, Frigo A, Covolo E, Facchin M, Isabella G, Gerosa G, Iliceto S. Unravelling the (arte)fact of increased pacemaker rate with the Edwards SAPIEN 3 valve. EuroIntervention. 2015 Jul;11(3):343-50. Cerca con Google

59. Popma JJ, D.H. Adams, M.J. Reardon, S.J. Yakubov, N.S. Kleiman, D. Heimansohn, J. Hermiller Jr., G.C. Hughes, J.K. Harrison, J. Coselli, J. Diez, A. Kafi, T. Schreiber, T.G. Gleason, J. Conte, M. Buchbinder, G.M. Deeb, B. Carabello, P.W. Serruys, S. Chenoweth, J.K. Oh, Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J. Am. Coll. Cardiol. 63 (2014) 1972–1981. Cerca con Google

60. Sinning JM, Hammerstingl C, Vasa-Nicotera M, Adenauer V, Lema Cachiguango SJ, Scheer AC, Hausen S, Sedaghat A, Ghanem A, Müller C, Grube E, Nickenig G, Werner N. Aortic regurgitation index defines severity of periprosthetic regurgitation and predicts outcome in patients after transcatheter aortic valve implantation. J Am Coll Cardiol. 2012 Mar 27;59(13):1134-41. Cerca con Google

61. Hayashida K, T. Lefevre, B. Chevalier, T. Hovasse, M. Romano, P. Garot, D. Mylotte, J. Uribe, A. Farge, P. Donzeau-Gouge, E. Bouvier, B. Cormier, M.C. Morice, Transfemoral aortic valve implantation new criteria to predict vascular complications, JACC Cardiovasc. Interv. 4 (2011) 851–858. Cerca con Google

62. .Moellmann H. Real-world experience using a 2nd generation self-expanding prosthesis: 1-year outcomes of 1000 patients enrolled in the SAVI-TF registry.presented EuroPCR 2017. Cerca con Google

63. Meredith Am IT, Walters DL, Dumonteil N, Worthley SG, Tchétché D, Manoharan G, Blackman DJ, Rioufol G, Hildick-Smith D, Whitbourn RJ, Lefèvre T, Lange R, Müller R, Redwood S, Allocco DJ, Dawkins KD. Transcatheter aortic valve replacement for severe symptomatic aortic stenosis using a repositionable valve system: 30-day primary endpoint results from the REPRISE II study. J Am Coll Cardiol. 2014 Sep 30;64(13):1339-48. Cerca con Google

64. Meredith IT, Walters DL, Dumonteil N, Worthley SG, Tchétché D, Manoharan G, Blackman DJ, Rioufol G, Hildick-Smith D, Whitbourn RJ, Lefèvre T, Lange R, Müller R, Redwood S, Feldman TE, Allocco DJ, Dawkins KD. 1-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results of the REPRISE II Study. JACC Cardiovasc Interv. 2016 Feb 22;9(4):376-384. Cerca con Google

65. Zamorano JL, Badano LP, Bruce C, et al. EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. Eur Heart J 2011;32:2189–214. Cerca con Google

66. Nashef SAM, Roques F, Michel P, et al. European System for Cardiac Operative Risk Evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999;16:9–13. Cerca con Google

67. Leon MB, Piazza N, Nikolsky E, et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J 2011;32:205–17. Cerca con Google

68. Kappetein AP, Head SJ, Gènèreux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Eur Heart J 2012;33:2403–18. Cerca con Google

69. Kappetein P, Head SJ, GénéreuxP, Piazza N, van Mieghem N, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es GA, Hahn RT, Kirtane AJ, Krucoff MW, Kodali S, Mack MJ, Mehran R, Rode´ s-Cabau J, Vranckx P, Webb JG, Windecker S, Serruys PW, Leon MB. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. European Heart Journal (2012) 33, 2403–2418 Cerca con Google

70. Thomas M, Schymik G, Walther T, Himbert D, Lefèvre T, Treede H, Eggebrecht H, Rubino P, Michev I, Lange R, Anderson WN, Wendler O: Thirty-Day Results of the SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry. A European Registry of Transcatheter Aortic Valve Implantation Using the Edwards SAPIEN Valve. Circulation.2010;122:62-69. Cerca con Google

71. Wendler O, Schymik G, Treede H, Baumgartner H, Dumonteil N, Ihlberg L, Neumann FJ, Tarantini G, Zamarano JL, Vahanian A. SOURCE 3 Registry: Design and 30-Day Results of the European Postapproval Registry of the Latest Generation of the SAPIEN 3 Transcatheter Heart Valve. Circulation. 2017 Mar 21;135(12):1123-1132 Cerca con Google

72. Iung B, Laouénan C, Himbert D, Eltchaninoff H, Chevreul K, Donzeau-Gouge P, Fajadet J, Leprince P, Leguerrier A, Lièvre M, Prat A, Teiger E, Laskar M, Vahanian A, Gilard M; FRANCE 2 Investigators. Predictive factors of early mortality after transcatheter aortic valve implantation: individual risk assessment using a simple score. Heart. 2014 Jul;100(13):1016-23. doi: 10.1136/heartjnl-2013-305314. Epub 2014 Apr 16 Cerca con Google

73. Barbash IM, Finkelstein A, Barsheshet A, Segev A, Steinvil A, Assali A, et al. Outcomes of Patients at Estimated Low, Intermediate, and High Risk Undergoing Transcatheter Aortic Valve Implantation for Aortic Stenosis. The American Journal of Cardiology 2015 December 15,;116(12):1916-1922. Cerca con Google

74. Jabbour RJ, Pagnesi M, Kawamoto H, Tanaka A, Regazzoli D, Mangieri A, et al. Transcatheter aortic valve implantation in intermediate- and low-risk populations: An inevitable progression? International Journal of Cardiology 2016 May 1,;210:35-37. Cerca con Google

75. D'Ascenzo F, Ballocca F, Moretti C, Barbanti M, Gasparetto V, Mennuni M, et al. Inaccuracy of available surgical risk scores to predict outcomes after transcatheter aortic valve replacement. J Cardiovasc Med (Hagerstown) 2013 Dec;14(12):894-898. Cerca con Google

76. Silaschi M, Conradi L, Seiffert M, Schnabel R, Schon G, Blankenberg S, et al. Predicting Risk in Transcatheter Aortic Valve Implantation: Comparative Analysis of EuroSCORE II and Established Risk Stratification Tools. Thorac Cardiovasc Surg 2015 Sep;63(6):472-478. Cerca con Google

77. Wenaweser P, Stortecky S, Schwander S, Heg D, Huber C, Pilgrim T, et al. Clinical outcomes of patients with estimated low or intermediate surgical risk undergoing transcatheter aortic valve implantation. Eur Heart J 2013 Jul;34(25):1894-1905. Cerca con Google

78. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients. New England Journal of Medicine 2011 June 9,;364(23):2187-2198. Cerca con Google

79. Barbanti M, Schiltgen M, Verdoliva S, Bosmans J, Bleiziffer S, Gerckens U, et al. Three-Year Outcomes of Transcatheter Aortic Valve Implantation in Patients With Varying Levels of Surgical Risk (from the CoreValve ADVANCE Study). The American Journal of Cardiology 2016 March 1,;117(5):820-827. Cerca con Google

80. Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. The New England journal of medicine 2016 Apr 28,;374(17):1609. Cerca con Google

81. Rodes-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Feindel CM, et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 2010 Mar 16;55(11):1080-1090. Cerca con Google

82. Zahn R, Gerckens U, Linke A, Sievert H, Kahlert P, Hambrecht R, et al. Predictors of one-year mortality after transcatheter aortic valve implantation for severe symptomatic aortic stenosis. Am J Cardiol 2013 Jul 15;112(2):272-279. Cerca con Google

83. Giordana F, D'Ascenzo F, Nijhoff F, Moretti C, D'Amico M, Biondi Zoccai G, et al. Meta-analysis of predictors of all-cause mortality after transcatheter aortic valve implantation. Am J Cardiol 2014 Nov 1;114(9):1447-1455. Cerca con Google

84. Gargiulo G, Capodanno D, Sannino A, Perrino C, Capranzano P, Stabile E, Trimarco B, Tamburino C, Esposito G. Impact of moderate preoperative chronic kidney disease on mortality after transcatheter aortic valve implantation. Int J Cardiol. 2015;189:77-8. Cerca con Google

85. Thourani VH, Forcillo J, Beohar N, Doshi D, Parvataneni R, Ayele GM, et al. Impact of Preoperative Chronic Kidney Disease in 2,531 High-Risk and Inoperable Patients Undergoing Transcatheter Aortic Valve Replacement in the PARTNER Trial. Ann Thorac Surg 2016 Oct;102(4):1172-1180. Cerca con Google

86. Chakos A, Wilson-Smith A, Arora S, Nguyen TC, Dhoble A, Tarantini G, Thielmann M, Vavalle JP, Wendt D, Yan TD, Tian DH. Long term outcomes of transcatheter aortic valve implantation (TAVI): a systematic review of 5-year survival and beyond. Ann Cardiothorac Surg. 2017 Sep;6(5):432-443. Cerca con Google

87. Gargiulo G, Sannino A, Capodanno D, Perrino C, Capranzano P, Barbanti M, Stabile E, Trimarco B, Tamburino C, Esposito G. Impact of postoperative acute kidney injury on clinical outcomes after transcatheter aortic valve implantation: A meta-analysis of 5,971 patients. Catheter Cardiovasc Interv. 2015 Sep;86(3):518-27 Cerca con Google

88. Barbanti M, Petronio AS, Ettori F, Latib A, Bedogni F, De Marco F, Poli A, Boschetti C, De Carlo M, Fiorina C, Colombo A, Brambilla N, Bruschi G, Martina P, Pandolfi C, Giannini C, Curello S, Sgroi C, Gulino S, Patane` M, Ohno Y, Tamburino C, Attizzani GF, Imme` S, Gentili A, Tamburino C. 5-year outcomes after transcatheter aortic valve implantation with corevalve prosthesis. JACC Cardiovasc Interv 2015;8:1084–1091. Cerca con Google

89. Gargiulo G, Sannino A, Capodanno D, et al. Impact of postoperative acute kidney injury on clinical outcomes after transcatheter aortic valve implantation: a meta-analysis of 5,971 patients. Catheter Cardiovasc Interv 2015;86:518–27. Cerca con Google

90. Xiong TY, Liao YB, Zhao ZG, Xu YN, Wei X, Zuo ZL, et al. Causes of Death Following Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis. J Am Heart Assoc 2015 Sep 21;4(9):e002096 Cerca con Google

91. Gargiulo G, Capodanno D, Sannino A, Perrino C, Capranzano P, Stabile E, Trimarco B, Tamburino C, Esposito G.. Impact of postoperative acute kidney injury on clinical outcomes after transcatheter aortic valve implantation: a meta-analysis of 5,971 patients. Catheter Cardiovasc Interv 2015;86: 518–27. Cerca con Google

92. Franzone A, Stortecky S, Pilgrim T, Asami M, Lanz J, Heg D, Langhammer B, Piccolo R, Lee JKT, Praz F, Räber L, Valgimigli M, Roost E, Windecker S. Incidence and impact of renal dysfunction on clinical outcomes after transcatheter aortic valve implantation. Int J Cardiol. 2017 Oct 3. pii: S0167-5273(17)33885-8. Cerca con Google

93. Van Mieghem NM, van der Boon RM, Nuis RJ, et al. Cause of death after transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2014;83:E277-82. Cerca con Google

94. Thomas M, Schymik G, Walther T, et al. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome(SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2011;124:425-33 Cerca con Google

95. Saia F, Latib A, Ciuca C, Gasparetto V, Napodano M, Sticchi A, Anderlucci L, Marrozzini C, Naganuma T, Alfieri O, Facchin M, Hoxha B, Moretti C, Marzocchi A, Colombo A, Tarantini G. Causes and timing of death during long-term follow-up after transcatheter aortic valve replacement. Am Heart J. 2014 Nov;168(5):798-806. Cerca con Google

96. Tarantini G, Gasparetto V, Napodano M, Frigo AC, Fraccaro C, Buja P, D'Onofrio A, D'Amico G, Barioli A, Baritussio A, Facchin M, Dariol G, Isabella G, Gerosa G, Iliceto S. Transcatheter aortic valve implantation and bleeding: Focus on Valve Academic Research Consortium-2. Int J Cardiol. 2013 Oct 12;168(5):5001-3. Cerca con Google

97. Clavel MA, Webb JG, Pibarot P, Altwegg L, Dumont E, Thompson C, De Larochelliere R, Doyle D, Masson JB, Bergeron S, Bertrand OF, Rodes-Cabau J. Comparison of the hemodynamic performance of percutaneous and surgical bioprostheses for the treatment of severe aortic stenosis. J Am Coll Cardiol. 2009;53:1883-1891. Cerca con Google

98. Clavel MA, Rodes-Cabau J, Dumont E, Bagur R, Bergeron S, De Larochelliere R, Doyle D, Larose E, Dumesnil JG, Pibarot P. Validation and characterization of transcatheter aortic valve effective orifice area measured by Doppler echocardiography. JACC Cardiovasc Imaging. 2011;4:1053-1062. Cerca con Google

99. Daubert MA, Weissman NJ, Hahn RT, Pibarot P, Parvataneni R, Mack MJ, Svensson LG, Gopal D, Kapadia S, Siegel RJ, Kodali SK, Szeto WY, Makkar R, Leon MB, Douglas PS. Long-term valve performance of TAVR and SAVR: a report from the PARTNER I trial. JACC Cardiovasc Imaging 2016; doi: 10.1016/j.jcmg.2016.11.004. Cerca con Google

100. Bourguignon T, Bouquiaux-Stablo AL, Candolfi P, et al. Very long-term outcomes of the Carpentier-Edwards Perimount Valve in aortic position. Ann Thorac Surg 2015;99:831–7. Cerca con Google

101. Deeb GM, Reardon MJ, Chetcuti S, Patel HJ, Grossman PM, Yakubov SJ, Kleiman NS, Coselli JS, Gleason TG, Lee JS, Hermiller JB, Heiser J, Merhi W, Zorn GL, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Maini B, Mumtaz M, Conte J, Resar J, Aharonian V, Pfeffer T, Oh JK, Qiao H, Adams DH, Popma JJ: CoreValve US Clinical Investigators. 3-Year outcomes in high-risk patients who underwent surgical or transcatheter aortic valve replacement. J Am Coll Cardiol 2016;67:2565–2574. Cerca con Google

102. Rahimtoola SH. Choice of prosthetic heart valve in adults an update. J Am Coll Cardiol 2010;55:2413–2426. Cerca con Google

103. Mylotte D, Andalib A, The´riault-Lauzier P, Dorfmeister M, Girgis M, Alharbi W, Chetrit M, Galatas C, Mamane S, Sebag I, Buithieu J, Bilodeau L, de Varennes B, Lachapelle K, Lange R, Martucci G, Virmani R, Piazza N. Transcatheter heart valve failure: a systematic review. Eur Heart J 2015;36:1306–1327. Cerca con Google

104. Webb JG, Dvir D. Is transcatheter aortic valve replacement a durable therapeutic strategy? JACC Cardiovasc Interv 2015;8:1092–1094. Cerca con Google

Download statistics

Solo per lo Staff dell Archivio: Modifica questo record